The Week Ahead
The Independent Citizens' Oversight Committee of the California Institute for Regenerative Medicine will vote on a proposed intellectual property policy for private companies that receive CIRM grants. The proposed rules would require companies to pay the state 1% to 3% of profit earned from discoveries made using state funds. The policy also would give full intellectual property protection to companies looking to market spinoff products from discoveries made with state funding.This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.